特発性肺線維症(Idiopathic Pulmonary Fibrosis):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2016315)
◆英語タイトル:Idiopathic Pulmonary Fibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2016315
◆発行日:2019年02月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD2,000 ⇒換算¥218,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥654,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[特発性肺線維症(Idiopathic Pulmonary Fibrosis):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)]についてメールでお問い合わせはこちら
※当調査レポートでは、特発性肺線維症(Idiopathic Pulmonary Fibrosis)治療薬の世界市場動向について調査・分析し、以下の構成でお届けいたします。

・特発性肺線維症(Idiopathic Pulmonary Fibrosis):適応症(疾患)の概要
・市販医薬品の状況
・世界のAPI(医薬品原薬)メーカー分析
・地域別APIメーカー状況(アメリカ、ヨーロッパ、中国など)
・特発性肺線維症(Idiopathic Pulmonary Fibrosis)のフェーズ3治験薬の状況
・特発性肺線維症(Idiopathic Pulmonary Fibrosis)治療薬の市場規模(販売予測)
・特発性肺線維症(Idiopathic Pulmonary Fibrosis)の市販医薬品分析
 (医薬品名、説明、APIメーカー、承認状況、特許など)
・特発性肺線維症(Idiopathic Pulmonary Fibrosis)のフェーズ3治験薬分析
・開発中止中の特発性肺線維症(Idiopathic Pulmonary Fibrosis)治療薬剤
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s Report, “Idiopathic Pulmonary Fibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Idiopathic Pulmonary Fibrosis Report is to understand the market and pipeline status of the drugs around the Idiopathic Pulmonary Fibrosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2020. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Idiopathic Pulmonary Fibrosis. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


SCOPE:
• A snapshot of the global Market and Phase III therapeutics scenario for Idiopathic Pulmonary Fibrosis.
• A review of the marketed products under prescription for Idiopathic Pulmonary Fibrosis, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Idiopathic Pulmonary Fibrosis with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Idiopathic Pulmonary Fibrosis drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Idiopathic Pulmonary Fibrosis drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Idiopathic Pulmonary Fibrosis drugs.
• Coverage of Idiopathic Pulmonary Fibrosis Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure to 2020.


*** レポート目次(コンテンツ)***

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2020
6. Marketed Drugs for Idiopathic Pulmonary Fibrosis
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Idiopathic Pulmonary Fibrosis
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Idiopathic Pulmonary Fibrosis
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables
• Idiopathic Pulmonary Fibrosis Therapeutic Market, US, Marketed Drugs by Application Type, 2018
• Idiopathic Pulmonary Fibrosis Therapeutic Market, US, Marketed Drugs by Marketing Status, 2018
• Idiopathic Pulmonary Fibrosis Therapeutic Market, US, (Year), 2018
• Idiopathic Pulmonary Fibrosis Marketed Drugs, API Manufacturers by US DMF Status, 2018
• Idiopathic Pulmonary Fibrosis Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• Idiopathic Pulmonary Fibrosis Drugs, API Manufacturers, Europe by Country, 2018
• Idiopathic Pulmonary Fibrosis Drugs, API Manufacturers, India by State, 2018
• Idiopathic Pulmonary Fibrosis Drugs, API Manufacturers, China by Province, 2018
• Idiopathic Pulmonary Fibrosis Drugs, API Manufacturers by Geography 2018
• Idiopathic Pulmonary Fibrosis Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• Idiopathic Pulmonary Fibrosis Therapeutic Market, Global Sales-2020 (in million USD)
• API Manufacturers for Drug, 2018
• Phase III Drugs for Idiopathic Pulmonary Fibrosis, 2018
• Discontinued Drugs for Idiopathic Pulmonary Fibrosis, 2018


List of Figures
• Idiopathic Pulmonary Fibrosis Therapeutic Market, US, Marketed Drugs by Application Type (%), 2018
• Idiopathic Pulmonary Fibrosis Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2018
• Idiopathic Pulmonary Fibrosis Therapeutic Market, US, (Year), 2018
• Idiopathic Pulmonary Fibrosis Marketed Drugs, API Manufacturers by US DMF Status (%), 2018
• Idiopathic Pulmonary Fibrosis Marketed Drugs, US DMF Status Drug Specific (Number), 2018
• Idiopathic Pulmonary Fibrosis Drugs, API Manufacturers, Europe by Country, 2018
• Idiopathic Pulmonary Fibrosis Drugs, API Manufacturers, India by State, 2018
• Idiopathic Pulmonary Fibrosis Drugs, API Manufacturers, China by Province, 2018
• Idiopathic Pulmonary Fibrosis Drugs, API Manufacturers by Geography 2018
• Idiopathic Pulmonary Fibrosis Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2018
• Idiopathic Pulmonary Fibrosis Therapeutic Market, Global Sales 2020 (in million USD)
• Drug, Patent/Exclusivity Expiry (Year), 2018


*** レポートのキーワード ***

特発性肺線維症(Idiopathic Pulmonary Fibrosis)、薬剤、治療薬、市場規模、販売量、医薬品有効成分(API)メーカー、治験、上市品(市販薬)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • ディーゼル車排気システムの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Diesel Vehicle Exhaust System Revenue, means the sales value of Diesel Vehicle Exhaust System This report studies sales (consumption) of Diesel Vehicle Exhaust System in Global market, especially in United States, China, Europe and Japan, focuses on top players …
  • 軍事衛星市場:米国(~2022)
    SDI’s "Military Satellites Market in the United States to 2022: Market Brief", provides a top-level, quantitative view of historic and forecast expenditure of Military Satellites Market sector in United States. The information in this brief draws upon SDI’s in-depth, primary research and proprietary …
  • フルーツパウダー市場:北アメリカ(市場動向~2019)
    Synopsis Canadean’s, "Fruit Powders Market in North America to 2019: Market Guide" provides a snapshot of the Fruit Powders consumption in North America. The quantitative data in the report provides historic and forecast consumption data of the market by country, giving a simple overview of the Frui …
  • ラック・アンド・ピニオンの世界市場2015
    [2015 Deep Research Report on Global Rack and Piston Industry] is a professional and deep research report in this field. For overview analysis, the report introduces Air Separation Plant basic information including definition, classification, application, industry chain structure, industry overview, …
  • 世界のソーラーパネル材料市場2016
    2016 Global Solar Panel Materials Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Solar Panel Materials industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan …
  • トンソンハイケム(DONGSUNG HIGHCHEM CO., LTD)の企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
  • 冷凍・フリーズドライペットフードの世界市場:販売動向2018
    This report studies the global Frozen and Freeze-Dried Pet Food market status and forecast, categorizes the global Frozen and Freeze-Dried Pet Food market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japa …
  • 世界の血栓管理装置市場2017
    Notes:Sales, means the sales volume of Clot Management Devices Revenue, means the sales value of Clot Management Devices This report studies sales (consumption) of Clot Management Devices in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/ …
  • 食用さなぎ の世界及び中国市場 2018年
    The 'Global and Chinese Silkworm chrysalis Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Silkworm chrysalis industry with a focus on the Chinese market. The report provides key statistics on the market status of the Silkworm chrys …
  • 株式会社ピジョン(PIGEON CORPORATION)の企業概要及び財務データ:韓国企業調査レポート
    韓国企業の概要及び財務データをまとめたレポートです。該当企業の設立日、住所、社員数、資本金、事業分野、連絡先、企業格付などの概要と、最近3年間の会計年度別貸借対照表(B/S)、損益計算書(P/L)、キャッシュ・フロー計算書(C/F)など財務データを調査しました。 韓国企業と取引する時、韓国に進出を検討する時、或いは韓国の競合企業を調べる時に、本データをご活用ください。追加のデータや詳しい情報が必要な場合は別途カスタムリサーチ(委託調査)サービスで対応致します。
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2016315 )"特発性肺線維症(Idiopathic Pulmonary Fibrosis):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)" (英文:Idiopathic Pulmonary Fibrosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。